Back to Blog

Supplements to Lower Homocysteine: B Vitamins and Beyond

February 27, 2026·4 min read

Homocysteine is an amino acid produced in the body from methionine metabolism. Elevated levels — above 15 micromol/L — damage the endothelial lining of blood vessels, promote arterial stiffness, oxidize LDL cholesterol, and increase clotting tendency. Population studies consistently link elevated homocysteine to significantly higher risk of heart attack, stroke, and cognitive decline.

Why Homocysteine Rises

Homocysteine is processed by two major metabolic pathways — remethylation (converting it back to methionine, requiring B12 and folate) and transsulfuration (converting it to cysteine, requiring B6). When these pathways are impaired — due to B vitamin deficiency, genetic variants in methylation enzymes, or chronic disease — homocysteine accumulates.

The most common cause of high homocysteine is deficiency of folate, B12, or B6 — all addressable through diet and supplementation.

Folate: The Primary Homocysteine Reducer

Folate in the active form (5-methyltetrahydrofolate, or 5-MTHF) is the methyl donor for remethylation of homocysteine. Supplementing folate at 400–800 mcg daily reduces homocysteine by 25% on average in those who are folate-deficient or have mild hyperhomocysteinemia.

Critical consideration: The MTHFR C677T genetic variant, present in 10–15% of Northern European populations, severely impairs folate conversion to 5-MTHF. Individuals with this variant must use methylfolate (5-MTHF) — not folic acid — to effectively lower homocysteine. Folic acid supplementation in MTHFR carriers may be inadequate or counterproductive.

Vitamin B12: Essential Co-Factor

B12 works alongside folate in the methylation cycle. B12 deficiency is common in older adults (due to reduced intrinsic factor production), vegetarians and vegans, metformin users, and those taking proton pump inhibitors. Supplementing methylcobalamin (the active, neurologically preferred form) at 500–1,000 mcg daily addresses deficiency and supports homocysteine reduction.

The combination of 5-MTHF and methylcobalamin addresses both halves of the remethylation equation.

Vitamin B6 for the Transsulfuration Pathway

B6 (as pyridoxal-5-phosphate, or P5P) is the cofactor for cystathionine beta-synthase, the enzyme that diverts homocysteine into the transsulfuration pathway. B6 deficiency impairs this alternative clearance route. Supplementing 25–50 mg of P5P (the active form) daily supports complete homocysteine metabolism.

The combination of folate + B12 + B6 consistently produces the greatest homocysteine reductions in clinical trials — often 30–40% in those with elevated baseline levels.

Betaine (TMG)

Betaine (trimethylglycine) is a methyl donor that can convert homocysteine to methionine through a folate-independent pathway using the enzyme betaine-homocysteine methyltransferase. This makes it particularly useful as a fallback in MTHFR variants and as an adjunct to B vitamin therapy.

Studies show 1,500–3,000 mg of betaine daily reduces homocysteine by 20–30% in hyperhomocysteinemia. It also has additional benefits for liver health and methylation capacity.

Riboflavin (B2) for MTHFR Variants

Riboflavin is a cofactor for MTHFR enzyme activity. In individuals with the MTHFR 677TT genotype, riboflavin supplementation at 1.6 mg daily significantly reduces homocysteine levels even without additional folate. This is a relatively underappreciated intervention for MTHFR-associated hyperhomocysteinemia.

Testing Homocysteine

A fasting plasma homocysteine test is a simple blood test available through standard labs. Optimal levels are below 7–9 micromol/L; values above 15 are defined as hyperhomocysteinemia. Given its cardiovascular relevance and the simplicity of B vitamin correction, testing is worthwhile in adults with any cardiovascular risk factors or family history of early heart disease.

FAQ

Q: Does lowering homocysteine actually reduce heart attack risk? A: Trials of B vitamin supplementation reduce homocysteine consistently but have produced mixed cardiovascular event outcomes. The strongest evidence is for stroke reduction. Treating homocysteine is prudent for overall vascular health, particularly when combined with other cardiovascular risk reduction.

Q: How do I know if I have an MTHFR variant? A: Genetic testing through 23andMe or a physician-ordered MTHFR gene test identifies C677T and A1298C variants. Many functional medicine physicians test routinely in patients with elevated homocysteine.

Q: Can I take too much folate? A: High-dose folic acid (above 1,000 mcg) may mask B12 deficiency symptoms and in MTHFR variants may accumulate as unmetabolized folic acid. Stick to 5-MTHF at appropriate doses rather than high-dose folic acid.

Q: What is the target homocysteine level? A: Below 10 micromol/L is widely accepted as safe. Many longevity-focused practitioners target below 7 micromol/L for optimal cognitive and vascular protection.

Related Articles

Track your supplements in Optimize.

Want to optimize your health?

Create your free account and start tracking what matters.

Sign Up Free